The latest updates on our research and how it is improving people’s lives.
MRC funding awarded to Kennedy researchers
8 September 2022
Funding Inflammation biology Kennedy Main
Two new projects led by Tal Arnon and Irina Udalova have been awarded Medical Research Council (MRC) funding.
Daniel Prieto-Alhambra receives ISPE award for COVID-19 research
1 September 2022
Awards Coronavirus COVID-19 Main
Daniel Prieto-Alhambra has been awarded the 'Special ISPE award for contributions to public health associated with the COVID-19 pandemic.'
Junqing Xie awarded by the International Society for Pharmacoepidemiology
30 August 2022
Awards Botnar Coronavirus COVID-19 Main
Congratulations to Junqing (Frank) Xie who has been awarded the Stanley A. Edlavitch Award from The International Society for Pharmacoepidemiology (ISPE).
Going straight to surgery found to be better than undergoing rehabilitation first for longstanding anterior cruciate ligament injury
23 August 2022
New research, funded by the National Institute for Health and Care Research (NIHR), shows initial surgery to be more successful and cost effective than undergoing treatment with rehabilitation first to treat longstanding anterior cruciate ligament injury.
Higher risk of blood clots in COVID-19 outpatients, largely reduced after vaccination
19 August 2022
Coronavirus COVID-19 Main Statistics and epidemiology
Researchers at NDORMS have studied the association between ambulatory COVID-19 and short-term risk of venal thrombosis and the clinical and genetic risk factors predisposing them to developing post–COVID-19 thrombosis.
£1.2M to improve diagnosis of emergency spinal condition
3 August 2022
The National Institute for Health and Care Research has awarded an Advanced Fellowship to Dr David Metcalfe to study the diagnosis of the spinal condition, cauda equina syndrome.
Professor Chris Lavy appointed to WHO technical advisory group
2 August 2022
General Main Orthopaedics and trauma
Congratulations to Professor Chris Lavy, who has been appointed to the World Health Organization’s (WHO) technical advisory group for integrated clinical care for a period of two years.
Oxford receives NIHR funding to test anti-TNF on post operative delirium
27 July 2022
Funding Hip Main Orthopaedics and trauma Trauma
Researchers at the University of Oxford have been awarded a grant from the National Institute for Health and Care Research (NIHR) to investigate whether anti-tumour necrosis factor (TNF) therapy can reduce or prevent post operative delirium/cognitive deficit.
Gene variant links trigger finger and carpal tunnel syndrome
22 July 2022
A new NDORMS study, published in The Lancet Rheumatology, has found a genetic variant that increases the risk of both carpal tunnel syndrome and trigger finger, and opens the door for new therapies that involve blocking the IGF-1 pathway.
Kennedy programmes support early career researchers
21 July 2022
Since 2013 the Kennedy Institute of Rheumatology has been running a Career Development Programme, a scheme to help early career researchers launch their own independent laboratories, and more recently the Innovator Investigator Programme to bring new technologies to core research themes.
OCTRU collaboration boosts understanding of COVID vaccine response
21 July 2022
Working with researchers across multiple universities, the Oxford Clinical Trials Unit (OCTRU) played a key role in delivering results of the national VROOM trial (Vaccine Response On Off Methotrexate).
Welcome to the new Kennedy Trust CEO
12 July 2022
The Kennedy Trust has announced Dr Stephen Simpson as its new Chief Executive Officer from 1 July 2022.
Emergency departments to use the FORCE pathway for wrist fractures in children
6 July 2022
New research from the University of Oxford has shown that doctors can simplify treatment for the most common fracture in children, reducing NHS costs.
Kennedy researchers awarded funding to improve the understanding of inflammatory bowel diseases
5 July 2022
A new £1.5M grant from the Medical Research Council (MRC) to the Powrie Group at the Kennedy Institute will help define different pathotypes of inflammatory bowel diseases that could lead to better and more focused treatments for patients.
Yoshi Itoh wins the International Dupuytren Award 2022
30 June 2022
Yoshi Itoh, Associate Professor and Principal Investigator Cell Migration Group at the Kennedy Institute has been awarded the International Dupuytren Award 2022.
Taking a break from immune-suppressing medicines doubles the antibody response to COVID-19 booster vaccination
29 June 2022
Coronavirus COVID-19 Main Trials
The Oxford Clinical Trials Research Unit (OCTRU) at NDORMS played a key role in the VROOM study which found that pausing immune-suppressing medicines such as methotrexate can increase the response to COVID-19 booster jabs.
Ten Years of Athena Swan in the Medical Sciences Division
24 June 2022
Equality and diversity General Main
2022 marks ten years since the first Athena Swan Bronze applications from the Medical Sciences Division. Ten years later, and all 16 departments in the Division have achieved a Silver Award. We look at NDORMS’ Athena Swan journey.
NDORMS researchers awarded Associate Professor title
22 June 2022
The University of Oxford has awarded the title of Associate Professor to Adam Cribbs and Luke Jostins.
Oxford's largest ever study into varicose veins shows need for surgery is linked to genetics
17 June 2022
A new international study by Oxford researchers published in Nature Communications, establishes for the first time a critical genetic risk score to predict the likelihood of patients suffering with varicose veins to require surgery, as well as pointing the way towards potential new therapies.
Reflecting on the role of Clinical Director of Trauma and Orthopaedics
13 June 2022
Botnar Main Orthopaedics and trauma
In 2021 Professor Andrew Price was appointed Clinical Director of Trauma and Orthopaedics at the Oxford University Hospitals NHS Foundation Trust. After 9 months in post, we find out what the challenges are and what he’s been able to bring to the role.